Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the treatment of metabolic disorders. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally https://loribbkx263267.mybjjblog.com/trelaglutide-exploring-a-new-option-for-chronic-diseases-51140267